More from the Author

• Case | HBS Case Collection | February 2019 (Revised August 2019)

  Maccabitech: The Promise of Israel's Healthcare Data

  Scott Duke Kominers and Carin-Isabel Knoop

  This case is set in mid-2019, when Qualcomm was struggling with unwanted takeover battles, fights with Apple and the Chinese government, and internal dissension on the board of directors. Ten years earlier Qualcomm was hailed as a monopoly on CDMA technologies and its derivatives—it appeared to be positioned to become the next dominant technology company in the tradition of Microsoft and Intel. But as the industry changed, Qualcomm’s competitive position seriously weakened. The purpose of the case is to explore central questions in strategy formulation: 1. how to build a long-term sustainable position based on technology, 2. how to design an IP strategy to lock in customers for the long run, 3. how to build a global standard and appropriate returns on that standard, and 4. how to respond when your historical business model starts to crumble.

  Keywords: big data; healthcare; Data and Data Sets; Two-Sided Platforms; Health Care and Treatment; Innovation and Invention; Research; Entrepreneurship; Risk Management; Israel;

  Citation:

  Kominers, Scott Duke, and Carin-Isabel Knoop. "Maccabitech: The Promise of Israel's Healthcare Data." Harvard Business School Case 819-032, February 2019. (Revised August 2019.)  View Details

  CiteView DetailsEducatorsPurchase

  Related

• Teaching Note | HBS Case Collection | July 2019

  Intermountain Healthcare: Pursuing Precision Medicine

  Richard G. Hamermesh, Robert S. Huckman and Julia Kelley

  Citation:

  Hamermesh, Richard G., Robert S. Huckman, and Julia Kelley. "Intermountain Healthcare: Pursuing Precision Medicine." Harvard Business School Teaching Note 820-019, July 2019.  View Details

  CiteView DetailsPurchase

  Related

• Case | HBS Case Collection | August 2018 (Revised March 2019)

  Facebook—Can Ethics Scale in the Digital Age?

  George A. Riedel and Carin-Isabel Knoop

  Since its founding in 2004, Facebook has built a phenomenally successful business at global scale to become the fifth most valuable public company in the world. The revelation of Cambridge Analytica events in March 2018, where 78 million users' information was leaked in a 2016 U.S. election cycle, exposed a breach of trust/privacy among its user community. In the past, growth at any costs appeared to be the de facto strategy. Now many voices such as regulators, advertisers, ethicists, shareholders and users argued for a more responsible approach to addressing their concerns. Mark Zuckerberg (CEO/Chair/Founder) and Sheryl Sandberg (COO) mapped out their six-point plan to address this existential threat. Could they continue to grow and rectify the breach of trust/privacy? Did other stakeholders have some greater responsibility too? In addition to issues of privacy and trust, there is a growing chorus of concern about “content moderation”—not for the easy topics like spam or copyright material—but for the hard things revolving around political points of view, hate speech, polarizing perspectives, etc. How will Facebook strike the balance between free speech and corrosive content across billions of users and dozens of languages? Are they the arbiters of truth/censorship in the digital world?

  Keywords: Ethics; Corporate Social Responsibility and Impact; Business and Stakeholder Relations; Trust; Business Model; Corporate Accountability;

  Citation:

  Riedel, George A., and Carin-Isabel Knoop. "Facebook—Can Ethics Scale in the Digital Age?" Harvard Business School Case 319-030, August 2018. (Revised March 2019.)  View Details

  CiteView DetailsEducatorsPurchase

  Related